Moxie Pharmaceutical Private Limited
About Moxie Pharmaceutical Private Limited
Data last updated:
Moxie Pharmaceutical Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24230OR2010PTC011766. Its GSTIN is 20AAICM1933D1Z2 (Jharkhand).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹34.5 Lakh. It is led by directors including Diwakar Tiwary and Santosh Kumar Bajpay.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot – 446 Chakeisiani, Bhubaneswar, Odisha, India – 751010.
As per the financials filed for FY 2023, the company reported a revenue of ₹23.15 Lakh, a decline of 62% compared to the previous year. For the same year it recorded a net loss of ₹10,129 (net margin -0.4%) and EBITDA of ₹2.98 Lakh (EBITDA margin 12.9%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 19% over five years.
As per MCA filings, the company has open charges of ₹15 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Moxie Pharmaceutical Private Limited's registered office is in Bhubaneswar, Odisha. Its e-mail address is in the company report.
- Email
- Registered AddressPlot – 446 Chakeisiani, Bhubaneswar, Odisha, India – 751010
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Moxie Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Moxie Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Moxie Pharmaceutical Private Limited, buy the company report.
Financials of Moxie Pharmaceutical Private Limited
FY 2023 filings availableMoxie Pharmaceutical Private Limited reported revenue of ₹23.15 Lakh (down 62% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 62% fall in the latest year. EBITDA rose 112% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10,129 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.9% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Moxie Pharmaceutical Private Limited, buy the company report.
Board of directors of Moxie Pharmaceutical Private Limited
Moxie Pharmaceutical has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Diwakar Tiwary | Director | 22 May 2019 | 7 Years 5 Months | Current |
| Santosh Kumar Bajpay | Director | 27 Jun 2020 | 6 Years 4 Months | Current |
| Anjan Kumar Dubey | Director | 08 Mar 2019 | 7 Years 8 Months | Current |
Auditor
Moxie Pharmaceutical Private Limited is audited by DIBAKAR AND ASSOCIATES for the financial year 2015.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DIBAKAR AND ASSOCIATES | FY 2015 | 326542E |
Shareholding
The shareholding of Moxie Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Moxie Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jan 2021 | 100445848 | Others | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Moxie Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Moxie Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Moxie Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAICM1933D1Z2 | Jharkhand | Active | 04 Jun 2018 |
To see the full GST registrations and return filing status of Moxie Pharmaceutical Private Limited, buy the company report.
Recent activity
Moxie Pharmaceutical Private Limited has 7 board changes on record since 2019: 3 appointments and 4 cessations. The latest: Anjan Kumar Dubey ceased to be Additional Director on 31 Dec 2020.
Frequently asked questions
Moxie Pharmaceutical is an active private limited company based in Bhubaneswar, Odisha, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 March 2010 (16+ years old) and is registered under CIN U24230OR2010PTC011766.
Moxie Pharmaceutical has 3 current directors:
- Diwakar Tiwary - Director
- Santosh Kumar Bajpay - Director
- Anjan Kumar Dubey - Director
The latest financial statements of Moxie Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Moxie Pharmaceutical is 20AAICM1933D1Z2, registered in Jharkhand.
The CIN (Corporate Identification Number) of Moxie Pharmaceutical is U24230OR2010PTC011766. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Moxie Pharmaceutical was incorporated on 24 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Cuttack.
Anjan Kumar Dubey ceased to be Additional Director on 31 Dec 2020. Diwakar Tiwary ceased to be Additional Director on 31 Dec 2020. Santosh Kumar Bajpay was appointed as Director on 27 Jun 2020. Moxie Pharmaceutical has 7 board changes on record in total.
The registered office of Moxie Pharmaceutical is at Plot – 446 Chakeisiani, Bhubaneswar, Odisha, India – 751010.
Moxie Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Moxie Pharmaceutical has open charges of ₹15 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
